Ulcerative colitis trials recruiting in California

All Ulcerative colitis trials nationally

Cities in California

Recruiting trials in California

• A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
  NCT06587828 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: Orange, Sherman Oaks
• A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
  NCT06405087 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · California: Loma Linda, Orange, Palo Alto
• A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
  NCT07185009 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female) · California: Coronado, Murrieta, Victorville
• A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
  NCT04844606 · Phase: Phase 3 · Ages: 2 Years to 19 Years · Sex: All (male and female) · California: San Francisco
• A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
  NCT07483073 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · California: Los Angeles, Oxnard
• A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
  NCT07196748 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · California: Anaheim, Coronado, Lancaster, Los Angeles
• A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
  NCT05076175 · Phase: Phase 2, Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · California: Garden Grove, Loma Linda, Los Angeles, Palo Alto
• A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
  NCT06598943 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Chula Vista, Coronado, Garden Grove, Lancaster
• A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
  NCT07577856 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Anaheim, Chula Vista, Los Alamitos, San Diego
• A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
  NCT07012395 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Canoga Park, La Jolla, Lancaster
• A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
  NCT06095128 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Los Angeles, Newport Beach
• A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
  NCT06581328 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · California: Escondido, Murrieta, Newport Beach, Orange
• A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
  NCT05442567 · Phase: Phase 3 · Ages: 2 Years and older · Sex: All (male and female) · California: Los Angeles, San Diego, San Francisco
• A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
  NCT06100289 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · California: Loma Linda, Orange, Palo Alto
• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
  NCT06588855 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female) · California: Apple Valley, Garden Grove, Lancaster, Los Angeles
• A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
  NCT07463183 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Anaheim, Coronado
• A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
  NCT05287126 · Phase: Phase 2 · Ages: 12 Years to 17 Years · Sex: All (male and female) · California: Garden Grove, Loma Linda, San Bernardino, San Francisco
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
  NCT06979336 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Lancaster, San Diego
• A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
  NCT06975722 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Escondido, Lancaster, Thousand Oaks
• A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
  NCT07071519 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · California: San Diego, San Francisco
• An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
  NCT07665723 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · California: Chula Vista
• An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
  NCT07184996 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female) · California: Arcadia, Canoga Park, Coronado, Folsom
• An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
  NCT06398626 · Phase: Not specified · Ages: 18 Years to 64 Years · Sex: All (male and female) · California: La Jolla, Los Alamitos
• BOOM-IBD2 Pivotal Clinical Trial
  NCT06571669 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · California: Folsom, Los Angeles, Newport Beach, Palo Alto
• Effects of Pomegranate Juice on Ulcerative Colitis
  NCT07115862 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• Fermented Food-Supplemented Diet in Ulcerative Colitis
  NCT04401605 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Palo Alto
• Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensity Focused Electromagnetic Stimulation
  NCT07034443 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
  NCT05987852 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · California: Los Angeles
• Impact of Prebiotics in Ulcerative Colitis
  NCT06495658 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · California: Los Angeles
• LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
  NCT07186101 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · California: Anaheim, Lancaster, Los Angeles
• LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
  NCT07415044 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · California: Anaheim, Folsom, Temple City, Victorville
• Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
  NCT06937086 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · California: Anaheim, Beverly Hills, Los Alamitos, Northridge
• Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients
  NCT04721873 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · California: La Jolla
• R-3750 in Patients With Mild to Moderate Ulcerative Colitis
  NCT05666960 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Valencia
• Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
  NCT07697456 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Anaheim, Lancaster, Los Alamitos, Rialto
• Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
  NCT06029972 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Chula Vista, Coronado, Garden Grove, La Jolla
• Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
  NCT06619990 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Palo Alto
• Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis
  NCT07686081 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Chula Vista
• Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
  NCT04314375 · Phase: Phase 4 · Ages: 5 Years to 17 Years · Sex: All (male and female) · California: Garden Grove
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
  NCT03816345 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Palo Alto, Sacramento
• The Influence of a Fasting Mimicking Diet on Ulcerative Colitis
  NCT03615690 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · California: Palo Alto
• The Use of Butyrate Therapy in Pediatric Ulcerative Colitis
  NCT05218850 · Phase: Phase 2 · Ages: 7 Years to 21 Years · Sex: All (male and female) · California: Los Angeles
• Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
  NCT05230173 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Irvine, La Jolla, Los Angeles, Palo Alto
• Understanding Ozanimod's MOA Via Mass Cytometry in Ulcerative Colitis
  NCT06311123 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: San Diego